Stay updated on Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial
Sign up to get notified when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.

Latest updates to the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.6%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedDifference0.3%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check57 days agoChange DetectedDifference0.3%
- Check64 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about the study objectives and bridging therapy for KTE-X19 in adult participants with relapsed/refractory B-precursor acute lymphoblastic leukemia. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference17%
Stay in the know with updates to Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.